BRIEF-Ocular Therapeutix says completes end-of-phase 2 review with FDA for OTX-TP for glaucoma and ocular hypertension

* Says completes end-of-phase 2 review with FDA for OTX-TP

for glaucoma and ocular hypertension

Read more